{
    "antigenSupportingData": {
        "contraindications": {
            "vaccineGroup": {
                "contraindication": [
                    {
                        "observationCode": "080",
                        "observationTitle": "Adverse reaction to vaccine component",
                        "contraindicationText": "Do not vaccinate if the patient has had an adverse reaction to a vaccine component."
                    },
                    {
                        "observationCode": "145",
                        "observationTitle": "B-lymphocyte [humoral] - Severe antibody deficiencies",
                        "contraindicationText": "Do not vaccinate if the patient has severe B-lymphocyte (humoral) - antibody deficiencies (e.g., X-linked agammaglobulinemia and common variable immunodeficiency)."
                    },
                    {
                        "observationCode": "146",
                        "observationTitle": "B-lymphocyte [humoral] - Less severe antibody deficiencies",
                        "contraindicationText": "Do not vaccinate if the patient has less severe B-lymphocyte (humoral) - antibody deficiencies (e.g., selective IgA deficiency and IgG subclass deficiency)."
                    },
                    {
                        "observationCode": "147",
                        "observationTitle": "T-lymphocyte [cell-mediated and humoral] - Complete defects",
                        "contraindicationText": "Do not vaccinate if the patient has complete cell-mediated or humoral T-lymphocyte defects (e.g., severe combined immunodeficiency [SCID] disease, complete DiGeorge syndrome)."
                    },
                    {
                        "observationCode": "148",
                        "observationTitle": "T-lymphocyte [cell-mediated and humoral] - Partial defects",
                        "contraindicationText": "Do not vaccinate if the patient has partial cell-mediated or humoral T-lymphocyte defects (e.g., most patients with DiGeorge syndrome, Wiskott-Aldrich syndrome, ataxia- telangiectasia)."
                    },
                    {
                        "observationCode": "150",
                        "observationTitle": "T-lymphocyte [cell-mediated and humoral] - interferon-gamma or interferon-alpha",
                        "contraindicationText": "Do not vaccinate if the patient has cell-mediated or humoral T-lymphocyte defects related to interferon-gamma or interferon-alpha"
                    },
                    {
                        "observationCode": "153",
                        "observationTitle": "Phagocytic function - Leukocyte adhesion defect, and myeloperoxidase deficiency",
                        "contraindicationText": "Do not vaccinate if the patient has a phagocytic function defect (e.g. leukocyte adhesion defect and myeloperoxidase deficiency)."
                    },
                    {
                        "observationCode": "154",
                        "observationTitle": "HIV/AIDS - severely immunocompromised",
                        "contraindicationText": "Do not vaccinate if the patient has HIV/AIDS and is severely immunocompromised (See the CDC general recommendations for a definition of \"severely immunocompromised\")."
                    },
                    {
                        "observationCode": "156",
                        "observationTitle": "Generalized malignant neoplasm",
                        "contraindicationText": "Do not vaccinate if the patient has generalized malignant neoplasm."
                    },
                    {
                        "observationCode": "157",
                        "observationTitle": "Solid organ transplantation",
                        "contraindicationText": "Do not vaccinate if the patient received a solid organ transplant.",
                        "contraindicationGuidance": "Certain immunosuppressive medications are administered to prevent solid organ transplant rejection. Live vaccines should be withheld for 2 months following discontinuation of anti-rejection therapies in patients with a solid organ transplant."
                    },
                    {
                        "observationCode": "158",
                        "observationTitle": "Immunosuppressive therapy",
                        "contraindicationText": "Do not vaccinate if the patient is undergoing immunosuppressive therapy. Immunosuppressive medications include those given to prevent solid organ transplant rejection, human immune mediators like interleukins and colony-stimulating factors, immune modulators like levamisol and BCG bladder-tumor therapy, and medicines like tumor necrosis factor alpha inhibitors and anti-B cell antibodies."
                    },
                    {
                        "observationCode": "159",
                        "observationTitle": "Radiation therapy",
                        "contraindicationText": "Do not vaccinate if the patient is undergoing radiation therapy."
                    },
                    {
                        "observationCode": "210",
                        "observationTitle": "Severe allergic reaction after previous dose of Dengue vaccine",
                        "contraindicationText": "Do not vaccinate if the patient has had a severe allergic reaction after a previous dose of Dengue vaccine."
                    },
                    {
                        "observationCode": "243",
                        "observationTitle": "Lack of laboratory confirmation of a previous Dengue infection",
                        "contraindicationText": "Do not vaccinate if the patient has had a severe allergic reaction after a previous dose of Dengue vaccine."
                    }
                ]
            }
        },
        "series": [
            {
                "seriesName": "Dengue risk 3-dose series",
                "targetDisease": "Dengue",
                "vaccineGroup": "Dengue",
                "seriesAdminGuidance": [
                    "Administer to persons with evidence of previous dengue infection and living in areas where dengue is endemic. Evidence of previous dengue infection, such as confirmation with previous laboratory-confirmed infection or a highly specific serodiagnostic test, will be required among eligible children before vaccination."
                ],
                "seriesType": "Risk",
                "selectSeries": {
                    "defaultSeries": "Yes",
                    "productPath": "No",
                    "seriesGroupName": "Increased Risk",
                    "seriesGroup": "1",
                    "seriesPriority": "A",
                    "seriesPreference": "1",
                    "maxAgeToStart": "17 years"
                },
                "indication": [
                    {
                        "observationCode": {
                            "text": "Evidence of previous dengue infection and living in areas where dengue is endemic",
                            "code": "211"
                        },
                        "description": "Administer to persons with evidence of previous dengue infection and living in areas where dengue is endemic.",
                        "beginAge": "9 years",
                        "endAge": "17 years",
                        "guidance": "Evidence of previous dengue infection, such as confirmation with previous laboratory-confirmed infection or a highly specific serodiagnostic test, will be required among eligible children before vaccination."
                    }
                ],
                "seriesDose": [
                    {
                        "doseNumber": "Dose 1",
                        "age": [
                            {
                                "absMinAge": "9 years - 4 days",
                                "minAge": "9 years",
                                "earliestRecAge": "9 years",
                                "maxAge": "17 years"
                            }
                        ],
                        "preferableVaccine": [
                            {
                                "vaccineType": "Dengue Fever",
                                "cvx": "56",
                                "beginAge": "9 years",
                                "endAge": "17 years",
                                "volume": "0.5",
                                "forecastVaccineType": "N"
                            }
                        ],
                        "allowableVaccine": [
                            {
                                "vaccineType": "Dengue Fever",
                                "cvx": "56",
                                "beginAge": "9 years - 4 days"
                            }
                        ],
                        "recurringDose": "No"
                    },
                    {
                        "doseNumber": "Dose 2",
                        "interval": [
                            {
                                "fromPrevious": "Y",
                                "absMinInt": "6 months - 4 days",
                                "minInt": "6 months",
                                "earliestRecInt": "6 months"
                            }
                        ],
                        "preferableVaccine": [
                            {
                                "vaccineType": "Dengue Fever",
                                "cvx": "56",
                                "beginAge": "9 years",
                                "endAge": "17 years",
                                "volume": "0.5",
                                "forecastVaccineType": "N"
                            }
                        ],
                        "allowableVaccine": [
                            {
                                "vaccineType": "Dengue Fever",
                                "cvx": "56",
                                "beginAge": "9 years - 4 days"
                            }
                        ],
                        "recurringDose": "No"
                    },
                    {
                        "doseNumber": "Dose 3",
                        "interval": [
                            {
                                "fromPrevious": "Y",
                                "absMinInt": "6 months - 4 days",
                                "minInt": "6 months",
                                "earliestRecInt": "6 months"
                            }
                        ],
                        "preferableVaccine": [
                            {
                                "vaccineType": "Dengue Fever",
                                "cvx": "56",
                                "beginAge": "9 years",
                                "endAge": "17 years",
                                "volume": "0.5",
                                "forecastVaccineType": "N"
                            }
                        ],
                        "allowableVaccine": [
                            {
                                "vaccineType": "Dengue Fever",
                                "cvx": "56",
                                "beginAge": "9 years - 4 days"
                            }
                        ],
                        "recurringDose": "No"
                    }
                ]
            }
        ]
    }
}